David K Ahern, PhD, (Abacus Chief Science Officer) Stephen J. Kogut, PhD, MBA, RPh and Jennifer Kellogg, MPH, (Healthy Weight Program Manager) have penned and article comparing the launch of Statin medications in the mid 1990s and the use of tobacco cessation to ultimately control cholesterol and reduce the risk of heart attacks,...
Balancing the Benefits of the New Anti-Obesity Medications with their Exorbitant Costs: What is a Self-Funded Employer to do?
Abacus' Sr Scientist, David Ahern, PhD and his Co-Authors: Collin Smith, PharmD, Augustus E. Adams, PhD, Michael J. Follick, PhD recently penned an opinion piece on the Obesity epidemic and its effects on self-funded employers. The article published on Healthcare Business Today, explored the impacts of obesity on self-funded employer...